No Effect of GLP-1s on Anti-VEGF Injection Frequency for Diabetic Macular Edema
(MedPage Today) -- NEW ORLEANS -- GLP-1 receptor agonists did not significantly affect anti-VEGF treatment frequency in patients with diabetic macular edema (DME), a large retrospective cohort study showed. Over 24 months of follow-up, "no sustained...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.